Pancreatic Neuroendocrine Tumors
635 articles
Picking the Right Team
Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
What to Eat—and What to Avoid—When You Have Pancreatic Cancer
The disease and treatment for pancreatic cancer affect the digestive system. Dietitian L.J. Amaral guides you to the best nutrition sources.
Surviving Pancreatic Cancer and Embracing Life
Joel Evans’ endocrinologist was concerned so he sent him to get tested for pancreatic cancer. It was caught early enough for a Whipple procedure.
Testing a Signal-Inhibiting Drug on Tumors with Specific Mutations
A new drug for certain tumor mutations is being tested in a type of clinical trial called a basket trial, which matches tumor genetics and drugs.
Noninvasive Surgery and a New Drug to Stop Pancreatic Tumors
A clinical trial combines irreversible electroporation (IRE) and immunotherapy to see if the duo is effective against locally advanced pancreatic cancer.
Stay Fit During Cancer Treatment
Researcher Christina Dieli-Conwright discusses the benefits of exercise during pancreatic cancer treatments, and ways patients can stay fit.
Symptom Management for Pancreatic Cancer Patients
Manage pancreatic cancer treatment symptoms and side effects with effective symptom management techniques from oncologist Dr. Kim A. Reiss.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
Multi-Site Precision Promise Study Opens
Dr. Vincent Picozzi explains how Precision Promise clinical trial will use a personalized approach for pancreatic cancer patients.
MORE Magazine: The Cancer Campaign That Got Personal
After a diagnosis of stage IV pancreatic cancer, Anne Glauber turned to research to find a treatment that could extend her life.
Immunology Researchers Solve a Mystery of Metastasis
Physician and researcher Douglas Fearon and his lab have a possible explanation for how cancer cells metastasize, and the role surgery may play in this process.
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
DIRECT Study Focuses on NanoKnife Technology
Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.